This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jun 20;25(18):2632-4; author reply 2634-5.

doi: 10.1200/JCO.2007.11.4330.

Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?

Carlo Capalbo, Amelia Buffone, Annarita Vestri, Enrico Ricevuto, Christian Rinaldi, Massimo Zani, Sergio Ferraro, Luigi Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini

PMID: 17577048
DOI: 10.1200/JCO.2007.11.4330

Comment

Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?

Carlo Capalbo et al. J Clin Oncol. 2007.

. 2007 Jun 20;25(18):2632-4; author reply 2634-5.

doi: 10.1200/JCO.2007.11.4330.

Authors

Carlo Capalbo, Amelia Buffone, Annarita Vestri, Enrico Ricevuto, Christian Rinaldi, Massimo Zani, Sergio Ferraro, Luigi Frati, Isabella Screpanti, Alberto Gulino, Giuseppe Giannini

PMID: 17577048
DOI: 10.1200/JCO.2007.11.4330

No abstract available

PubMed Disclaimer

Comment on

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC. Frank TS, et al. J Clin Oncol. 2002 Mar 15;20(6):1480-90. doi: 10.1200/JCO.2002.20.6.1480. J Clin Oncol. 2002. PMID: 11896095
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G. Berry DA, et al. J Clin Oncol. 2002 Jun 1;20(11):2701-12. doi: 10.1200/JCO.2002.05.121. J Clin Oncol. 2002. PMID: 12039933
Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
James PA, Doherty R, Harris M, Mukesh BN, Milner A, Young MA, Scott C. James PA, et al. J Clin Oncol. 2006 Feb 1;24(4):707-15. doi: 10.1200/JCO.2005.01.9737. J Clin Oncol. 2006. PMID: 16446345

Similar articles

Genomic rearrangements in the BRCA1 and BRCA2 genes.
Mazoyer S. Mazoyer S. Hum Mutat. 2005 May;25(5):415-22. doi: 10.1002/humu.20169. Hum Mutat. 2005. PMID: 15832305 Review.
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
Wolff TA, Wilson JE. Wolff TA, et al. Am Fam Physician. 2006 Nov 15;74(10):1759-60. Am Fam Physician. 2006. PMID: 17137007 Review. No abstract available.
Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients.
Rao NY, Hu Z, Yu JM, Li WF, Zhang B, Su FX, Wu J, Shen ZZ, Huang W, Shao ZM. Rao NY, et al. Breast Cancer Res Treat. 2009 Aug;116(3):563-70. doi: 10.1007/s10549-008-0181-4. Epub 2008 Sep 19. Breast Cancer Res Treat. 2009. PMID: 18807178
Optimal selection of individuals for BRCA mutation testing.
Evans DG, Lalloo F, Eccles D. Evans DG, et al. J Clin Oncol. 2006 Jul 10;24(20):3311; author reply 3311-2. doi: 10.1200/JCO.2006.06.6134. J Clin Oncol. 2006. PMID: 16829657 No abstract available.
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Hansen Tv, Jønson L, Albrechtsen A, Andersen MK, Ejlertsen B, Nielsen FC. Hansen Tv, et al. Breast Cancer Res Treat. 2009 May;115(2):315-23. doi: 10.1007/s10549-008-0088-0. Epub 2008 Jun 12. Breast Cancer Res Treat. 2009. PMID: 18546071

See all similar articles

Cited by

Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond.
Valentini V, Bucalo A, Conti G, Celli L, Porzio V, Capalbo C, Silvestri V, Ottini L. Valentini V, et al. Cancers (Basel). 2024 Jan 30;16(3):579. doi: 10.3390/cancers16030579. Cancers (Basel). 2024. PMID: 38339330 Free PMC article. Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information